Current Research on HIV Drug Resistance
HIV drug resistance is an unavoidable challenge for HIV/AIDS professionals, and it has long been a major obstacle hindering the global effort to contain HIV/AIDS. Pathogens journal launched a topical collection in 2021 on “Current Research on HIV Drug Resistance”, aiming to catch the latest advanc...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 electronic resource (152 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993573564804498 |
---|---|
ctrlnum |
(CKB)5470000001631600 (oapen)https://directory.doabooks.org/handle/20.500.12854/94485 (EXLCZ)995470000001631600 |
collection |
bib_alma |
record_format |
marc |
spelling |
Ji, Hezhao edt Current Research on HIV Drug Resistance Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (152 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier HIV drug resistance is an unavoidable challenge for HIV/AIDS professionals, and it has long been a major obstacle hindering the global effort to contain HIV/AIDS. Pathogens journal launched a topical collection in 2021 on “Current Research on HIV Drug Resistance”, aiming to catch the latest advancements in HIV resistance diagnosis, surveillance and research. This book compiles all articles published in this collection, combining original research and review articles on HIV drug resistance. English Medicine bicssc Epidemiology & medical statistics bicssc HIV drug resistance sanger sequencing next-generation sequencing interrupted antiretroviral therapy HIV-1 nef Botswana drug resistance mutations 3'-polypurine tract dolutegravir single genome sequencing drug resistance integrase strand transfer inhibitors replication fitness case study complex adaptive system leverage points systems mapping Dar es Salaam Tanzania HIV surveillance public health Mexico HIV pretreatment drug resistance HIV acquired drug resistance Mexico City antiviral therapy protease inhibitor protease mutation atazanavir HCV probe capture enrichment point-of-care test resource-limited setting testing analytes specimens performance 3-0365-5511-0 Ji, Hezhao oth |
language |
English |
format |
eBook |
author2 |
Ji, Hezhao |
author_facet |
Ji, Hezhao |
author2_variant |
h j hj |
author2_role |
Sonstige |
title |
Current Research on HIV Drug Resistance |
spellingShingle |
Current Research on HIV Drug Resistance |
title_full |
Current Research on HIV Drug Resistance |
title_fullStr |
Current Research on HIV Drug Resistance |
title_full_unstemmed |
Current Research on HIV Drug Resistance |
title_auth |
Current Research on HIV Drug Resistance |
title_new |
Current Research on HIV Drug Resistance |
title_sort |
current research on hiv drug resistance |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2022 |
physical |
1 electronic resource (152 p.) |
isbn |
3-0365-5512-9 3-0365-5511-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT jihezhao currentresearchonhivdrugresistance |
status_str |
n |
ids_txt_mv |
(CKB)5470000001631600 (oapen)https://directory.doabooks.org/handle/20.500.12854/94485 (EXLCZ)995470000001631600 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Current Research on HIV Drug Resistance |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652572493217792 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02744nam-a2200793z--4500</leader><controlfield tag="001">993573564804498</controlfield><controlfield tag="005">20231214132852.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202212s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-0365-5512-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5470000001631600</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/94485</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995470000001631600</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ji, Hezhao</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Current Research on HIV Drug Resistance</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (152 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">HIV drug resistance is an unavoidable challenge for HIV/AIDS professionals, and it has long been a major obstacle hindering the global effort to contain HIV/AIDS. Pathogens journal launched a topical collection in 2021 on “Current Research on HIV Drug Resistance”, aiming to catch the latest advancements in HIV resistance diagnosis, surveillance and research. This book compiles all articles published in this collection, combining original research and review articles on HIV drug resistance.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epidemiology & medical statistics</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIV drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sanger sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">next-generation sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interrupted antiretroviral therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIV-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nef</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Botswana</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug resistance mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">3'-polypurine tract</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dolutegravir</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">single genome sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">integrase strand transfer inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">replication fitness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">case study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">complex adaptive system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">leverage points</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systems mapping</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Dar es Salaam</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Tanzania</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">surveillance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">public health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mexico</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIV pretreatment drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HIV acquired drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mexico City</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiviral therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protease inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mutation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atazanavir</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HCV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">probe capture</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enrichment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">point-of-care test</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resource-limited setting</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">testing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">analytes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">specimens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">performance</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-5511-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ji, Hezhao</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:34:53 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-01-09 04:44:33 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5341789010004498&Force_direct=true</subfield><subfield code="Z">5341789010004498</subfield><subfield code="b">Available</subfield><subfield code="8">5341789010004498</subfield></datafield></record></collection> |